JPS63290808A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPS63290808A
JPS63290808A JP12654087A JP12654087A JPS63290808A JP S63290808 A JPS63290808 A JP S63290808A JP 12654087 A JP12654087 A JP 12654087A JP 12654087 A JP12654087 A JP 12654087A JP S63290808 A JPS63290808 A JP S63290808A
Authority
JP
Japan
Prior art keywords
chitosan
acid
water
salt
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12654087A
Other languages
Japanese (ja)
Other versions
JP2507425B2 (en
Inventor
Hiroshi Asano
裕志 浅野
Kazuo Uchida
和夫 内田
Shizuo Enokida
榎田 静雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIWA BUSSAN KK
Nitta Gelatin Inc
Original Assignee
EIWA BUSSAN KK
Nitta Gelatin Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EIWA BUSSAN KK, Nitta Gelatin Inc filed Critical EIWA BUSSAN KK
Priority to JP62126540A priority Critical patent/JP2507425B2/en
Publication of JPS63290808A publication Critical patent/JPS63290808A/en
Application granted granted Critical
Publication of JP2507425B2 publication Critical patent/JP2507425B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/736Chitin; Chitosan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To provide a safe cosmetic for skin or oral cavity, containing a water- soluble acid salt of chitosan as an active component, having high deodorization and antibacterial properties and exhibiting excellent bio-compatibility because of the absence of stimulation, toxicity, allergic activity, etc. CONSTITUTION:The objective antibacterial deodorant cosmetic contains >=1wt.% of a water-soluble acid salt of chitosan (e.g. hydrochloride, formate, acetate or L-aspartate). The chitosan salt can be produced by depolymerizing chitosan to a molecular weight of <=100,000, dispersing in water and adding an acid in an amount to give an aqueous chitosan salt solution having a pH of 3-6 under agitation. The above chitosan salt is suitable as a face lotion or cream for pimple, deodorant, gargle, wiping agent, etc.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 この発明は、防臭、抗菌効果を発揮する化粧料に関する
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] This invention relates to a cosmetic that exhibits deodorizing and antibacterial effects.

〔従来の技術〕[Conventional technology]

皮膚用、あるいは、口中用等の化粧料として、抗菌性物
質が配合された、防臭、抗菌効果を目的とするものがあ
る。たとえば、にきび用の化粧水やクリーム、デオドラ
ント剤、うがい剤、清拭用剤等がそれで、用途に応じ、
製品の形態に応じて、種々の抗菌性物質が配合されてい
る。また、化粧料自体の防腐のため、上記以外の化粧料
にも、これら抗菌性物質は配合されることが多い。
BACKGROUND ART Some cosmetics for the skin or the mouth contain antibacterial substances and are intended to have deodorizing and antibacterial effects. For example, lotions and creams for acne, deodorants, gargles, cleansing agents, etc.
Various antibacterial substances are blended depending on the form of the product. Furthermore, these antibacterial substances are often blended into cosmetics other than those mentioned above in order to preserve the cosmetics themselves.

抗菌性物質としては、たとえば、オキジドール(過酸化
水素水)、逆性石!(陽イオン活性剤)、クロルチモー
ル、サリチル酸、ザロール(サリチル酸フェニル)、石
炭酸(フェノール)、ニトロフラゾン、ヒノキチオール
、ヘキサクロロフェン、硼酸、硼酸ナトリウム等が一般
的に用いられている。
Examples of antibacterial substances include Oxidol (hydrogen peroxide) and Gyakusei Stone! (cation activator), chlorthymol, salicylic acid, zalol (phenyl salicylate), carbolic acid (phenol), nitrofurazone, hinokitiol, hexachlorophene, boric acid, sodium borate, etc. are commonly used.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

ところが、上記抗菌性物質は、防臭性、抗菌性とともに
、一般に、大なり小なり人体に対する刺激性、毒性、ア
レルギー性等の副作用を併せ持っており、それが為に、
化粧料を製造する際には、用途、目的等に応じて配合で
きる抗菌性物質の種類、量等が制限される。それととも
に、実際の使用にあたっても注意が必要となる。
However, in addition to deodorizing and antibacterial properties, the above-mentioned antibacterial substances generally have side effects such as irritation, toxicity, and allergy to the human body to a greater or lesser extent.
When manufacturing cosmetics, there are restrictions on the type, amount, etc. of antibacterial substances that can be added depending on the use, purpose, etc. At the same time, care must be taken in actual use.

この発明は、上記事情に鑑みて、防臭性、抗菌性が高く
、かつ、刺激性、毒性5アレルギー性等を有していない
ため生体適合性に優れた安全な抗菌性物質が配合された
化粧料を提供することを目的としている。
In view of the above circumstances, this invention provides cosmetics containing safe antibacterial substances that are highly biocompatible and highly deodorizing and antibacterial, and are not irritating, toxic, or allergic. The purpose is to provide fees.

〔問題点を解決するための手段〕[Means for solving problems]

上記問題に鑑みて、発明者らは、自然界に存在する抗菌
性物質に着目し、種々の化合物について、その防臭性や
抗菌性と生体適合性との関係を調べた。その結果、キチ
ンから得られるキトサンが、優れた防臭性、抗菌性なら
びに生体適合性を併せ持っていることがわかった。しか
し、このようなキトサンは、通常の状態では水に不溶の
固体であり、そのままの状態では、溶液、エマルション
等種々の形態からなる前記化粧料に応用することが難し
いものであった。そこで、□さらに検討を行った結果、
この発明を完成した。
In view of the above problems, the inventors focused on antibacterial substances that exist in nature, and investigated the relationship between the deodorizing properties, antibacterial properties, and biocompatibility of various compounds. As a result, it was found that chitosan obtained from chitin has excellent deodorizing properties, antibacterial properties, and biocompatibility. However, such chitosan is a solid that is insoluble in water in its normal state, and it has been difficult to apply it as it is to the cosmetics in various forms such as solutions and emulsions. Therefore, □As a result of further consideration,
completed this invention.

すなわち、この発明は、キトサンが水溶性酸塩の形で有
効成分として配合されていることを特徴とする化粧料を
要旨としている。
That is, the gist of the present invention is a cosmetic composition characterized by containing chitosan as an active ingredient in the form of a water-soluble acid salt.

〔作 用〕[For production]

以下、この発明の化粧料について、詳しく説明する。 The cosmetics of this invention will be explained in detail below.

この発明に用いられるキトサンの水溶性酸塩(以下「キ
トサン塩」と記す)は、エビ、カニ等の甲殻類の甲皮、
きのこ、細菌細胞壁等から得られるキチンを税アセチル
化することで得られるキトサンを、有機酸あるいは無機
酸と反応させることで得られる。
The water-soluble acid salt of chitosan (hereinafter referred to as "chitosan salt") used in this invention is the carapace of crustaceans such as shrimp and crabs,
Chitosan is obtained by acetylating chitin obtained from mushrooms, bacterial cell walls, etc., and is obtained by reacting it with an organic or inorganic acid.

キトサンは、一般に、平均分子量が20万以上で、酸に
対する溶解性が低いため、そのままの状態では、酸と充
分に反応させることができない傾向がある。そこで、酸
との反応にあたっては、あらかじめ、キトサンを分子量
10万以下に低分子量化したのち、酸と反応させること
が望ましい。
Chitosan generally has an average molecular weight of 200,000 or more and has low solubility in acids, so it tends to be unable to react sufficiently with acids in its original state. Therefore, in the reaction with an acid, it is desirable to lower the molecular weight of chitosan to 100,000 or less in advance and then react with the acid.

もちろん、キトサンは、低分子量化せず、そのまま用い
るようであってもよい。
Of course, chitosan may be used as it is without reducing its molecular weight.

キトサンの低分子量化の方法としては、酸化剤を用いた
化学処理法や、パパイン、セルラーゼ。
Methods for reducing the molecular weight of chitosan include chemical treatment using oxidizing agents, papain, and cellulase.

酸性プロテアーゼ等の酵素を用いた酵素処理法等が挙げ
られる。
Examples include enzyme treatment methods using enzymes such as acid protease.

上記のようなキトサンと反応する酸としては、無機酸、
有機酸のいずれを用いてもよい。無機酸としては塩酸等
が挙げられ、有機酸としては蟻酸、乳酸、酢酸、クエン
酸、グリコール酸、マロン酸、アスコルビン酸、アジピ
ン酸、シュウ酸、プロピオン酸、酒石酸、コハク酸、L
−グルタミン酸、L−アスパラギン酸等が挙げられる。
Acids that react with chitosan as mentioned above include inorganic acids,
Any organic acid may be used. Examples of inorganic acids include hydrochloric acid, and examples of organic acids include formic acid, lactic acid, acetic acid, citric acid, glycolic acid, malonic acid, ascorbic acid, adipic acid, oxalic acid, propionic acid, tartaric acid, succinic acid, and L.
-Glutamic acid, L-aspartic acid, etc.

なお、酸として硫酸を用いた場合には、得られるキトサ
ン塩が水溶性でなく水不溶性であり、充分な抗菌作用が
得られない。したがって、この発明の化粧料に配合され
るキトサン塩は、上記各酸との反応物たる水溶性酸塩で
ある必要がある。
In addition, when sulfuric acid is used as the acid, the obtained chitosan salt is not water-soluble but water-insoluble, and sufficient antibacterial action cannot be obtained. Therefore, the chitosan salt blended into the cosmetic of the present invention needs to be a water-soluble acid salt that is a reactant with each of the above acids.

これらキトサンと酸とを反応させるには、キトサンの粉
末に酸を加えればよいのであるが、これらのものだけで
は反応が急激に行われたり、所定の反応以外の副反応が
起こる可能性もあるため、通常、これらの反応は、水の
存在下で行われる。
In order to react these chitosan and acids, it is sufficient to add acid to the chitosan powder, but if only these substances are used, the reaction may occur rapidly or side reactions other than the intended reaction may occur. Therefore, these reactions are usually carried out in the presence of water.

また、この水は、反応によって生成されるキトサン塩を
所定の濃度の水溶液にするためにも必要となる。
Further, this water is also required to make the chitosan salt produced by the reaction into an aqueous solution of a predetermined concentration.

このような水を伴う反応の方法としては、キトサン粉末
を水に分散させ、それをかく拌しつつ酸を加える方法等
があるが、それ以外の方法を用いるようであってもよい
。また、以上のようにしてキトサンと酸とを反応させる
にあたり、キトサンを低分子量化するための前記分解酵
素をもこの反応系に添加し、キトサンの低分子量化と熔
解とを同時に行うこともできる。
As a method for such a reaction involving water, there is a method such as dispersing chitosan powder in water and adding an acid while stirring it, but other methods may also be used. In addition, in reacting chitosan with an acid as described above, the degrading enzyme for reducing the molecular weight of chitosan can also be added to the reaction system, thereby reducing the molecular weight of chitosan and melting it at the same time. .

酸の配合量は、この発明では特に限定されないが、キト
サンの遊離アミノ基を中和するに必要な量以上配合する
ことが好ましく、得られるキトサン塩の水溶液のpHが
3〜6の範囲内となる量配合することがより好ましい。
The amount of acid to be blended is not particularly limited in the present invention, but it is preferable to blend the acid in an amount greater than or equal to the amount necessary to neutralize the free amino groups of chitosan, and the pH of the resulting aqueous solution of chitosan salt is within the range of 3 to 6. It is more preferable to blend the amount.

上記のようなキトサン塩が配合されるのであれば化粧料
の種類は特に限定されず、この発明は、前述したにきび
用の化粧水やクリーム、デオドラント剤、うがい剤、清
拭用剤等を含む、皮膚用。
The type of cosmetic is not particularly limited as long as the above-mentioned chitosan salt is blended, and the present invention includes the above-mentioned acne lotion, cream, deodorant, gargle, cleaning agent, etc. , for skin.

ひげそり用2口中用等、あらゆる化粧料に適用すること
ができる。
It can be applied to all kinds of cosmetics, such as two-in-one use for shaving.

これら化粧料としては、たとえば、下記のものが挙げら
れるが、ここに示した以外のものであってもよいことは
、言うまでもない。
Examples of these cosmetics include the following, but it goes without saying that other cosmetics than those shown here may also be used.

■ 動植物油脂、動植物ロウ、鉱物性ロウ、炭化水素、
脂肪酸類等の油性成分を含む油性の、あるいは、上記油
性成分にさらに、非イオン性界面活性剤、カチオン性界
面活性剤9両性界面活性剤等の乳化剤が配合された乳状
の、クレンジングクリーム、クレンジングローション、
粘液性化粧水、乳液(乳化性化粧水)、2層式化粧水、
クリーム類、ファンデーション類、デオドラントクリー
ム、ゼリーシャンプー、クリームシャンプー、ひげそり
クリーム等。
■ Animal and vegetable oils, animal and vegetable waxes, mineral waxes, hydrocarbons,
Cleansing creams and cleansing creams that are oil-based, including oily components such as fatty acids, or emulsifying agents, such as nonionic surfactants, cationic surfactants, 9 amphoteric surfactants, etc., added to the above oily components. lotion,
Mucilage lotion, emulsion (emulsifying lotion), two-layer lotion,
Creams, foundations, deodorant creams, jelly shampoos, cream shampoos, shaving creams, etc.

■ 水溶性糖類、水溶性高分子化合物等を含む水溶液状
または水性ゲル状の、あるいは、アルコール類を基剤と
するアルコール性の、化粧水、デオドラントローション
、液体シャンプー、ひげそりローション、清拭用ローシ
ョン、うがい剤等。
■ Aqueous solution or gel containing water-soluble sugars, water-soluble polymer compounds, etc., or alcohol-based lotion, deodorant lotion, liquid shampoo, shaving lotion, and cleaning lotion. , mouthwash, etc.

■ 粉末状、固形状あるいはペースト状の石鹸類、ハウ
ダーファンデーション、ベビーパウター、制汗パウダー
、粉末シャンプー、歯磨き類等。
■ Powdered, solid or paste soaps, howder foundation, baby powder, antiperspirant powder, powdered shampoo, toothpaste, etc.

上記のような化粧料に配合される前記キトサン塩は、そ
の化粧料の形態によって、水溶液の状態のまま配合され
るようであってもよいし、水分を除去し、粉末化して配
合されるようであってもよい。
Depending on the form of the cosmetic, the chitosan salt may be blended in the form of an aqueous solution, or it may be blended after removing water and turning it into powder. It may be.

上述した各形態のうち、油性や粉末状のものでは水の存
在が好ましくないため、粉末化したキトサン塩を配合す
るようにする。なお、製法によっては、油性や粉末状で
も、キトサン塩を水溶液のまま配合することもできる。
Among the above-mentioned forms, since the presence of water is undesirable in oil-based and powdered forms, powdered chitosan salt is blended. Note that depending on the manufacturing method, chitosan salt can be blended as an aqueous solution, even if it is oil-based or powdered.

その他の形態の際には、キトサン塩は水溶液のまま配合
してもよいが、粉末化したキトサン塩を用いるようであ
ってもよい。その際には、水溶液よりもキトサン塩の濃
度を高められる、と言う利点がある。このようにキトサ
ン塩を粉末化する方法としては、噴霧乾燥、凍結乾燥等
、通常の乾燥方法を通用することができる。
In other forms, chitosan salt may be blended as an aqueous solution, but powdered chitosan salt may also be used. In this case, there is an advantage that the concentration of chitosan salt can be higher than that in an aqueous solution. As a method for pulverizing chitosan salt in this manner, ordinary drying methods such as spray drying and freeze drying can be used.

キトサン塩の添加量も、この発明では特に限定されない
が、化粧料に対するキトサン塩の添加量は1重量%以上
であることが好ましい。なぜなら、キトサン塩の添加量
が1重量%未満では、充分な抗菌、防臭効果が得られな
い恐れがあるからである。
Although the amount of chitosan salt added is not particularly limited in the present invention, it is preferable that the amount of chitosan salt added to the cosmetic is 1% by weight or more. This is because if the amount of chitosan salt added is less than 1% by weight, sufficient antibacterial and deodorizing effects may not be obtained.

これらキトサン塩の防臭、抗菌効果を調べるため、下記
試験を行った。
In order to investigate the deodorizing and antibacterial effects of these chitosan salts, the following tests were conducted.

1重量%酢酸水溶液に1重量%の対象キトサンを溶解し
たときの極限粘度から推定した推定分子量15,000
のキトサンの乳酸塩を、各々0.025〜0.25重量
%含むトリブチケースソイブロス培地(培養液)を作成
した。つぎに、あらかじめ、トリプチケースソイブロス
培地で37℃、2日間培養しておいた、臭気ならびに腐
敗の元となる下記5種類の菌株を、それぞれ、1d当た
りの菌数が100〜1000になるように、前記キトサ
ンの乳酸塩を含むトリプチケースソイブロス培地に接種
した。
Estimated molecular weight 15,000 estimated from the intrinsic viscosity when 1% by weight of target chitosan is dissolved in 1% by weight acetic acid aqueous solution
A tributicase soy broth medium (culture solution) containing 0.025 to 0.25% by weight of chitosan lactate was prepared. Next, the following 5 types of bacterial strains that cause odor and spoilage were cultured in Trypticase soy broth medium for 2 days at 37°C until the number of bacteria per 1 d was 100 to 1000. Trypticase soy broth medium containing chitosan lactate was inoculated as described above.

(使用菌株) Staphylococcus aureusBaci
llus 5ubtilis Bacillus segateriumLactob
acillus plantalutaLactoba
cillus sporogenesなお、上記各画な
らびに培地は以下のとおり。
(Used strain) Staphylococcus aureus Bacillus
llus 5ubtilis Bacillus segaterium Lactob
acillus plantaluta Lactoba
cillus sporogenes Each of the above images and the culture medium are as follows.

・5taphylococcus aureus  :
代表的な化膿球菌でブドウ球菌とも呼ばれる。
・5taphylococcus aureus:
A typical example of pyogenes is pyogenes, also called staphylococcus.

・Bacillus 5ubtilis  :枯草菌、
好気性ないし通性嫌気性菌で空中浮遊菌である。
・Bacillus 5ubtilis: Bacillus subtilis,
It is an aerobic or facultative anaerobic bacterium that is airborne.

・Bacillus megaterium  :従属
栄養菌の一種で、腐生菌、寄生菌、病原菌、あるいは、
共棲菌などがある。
・Bacillus megaterium: A type of heterotrophic bacterium, it is a saprophytic bacterium, a parasitic bacterium, a pathogenic bacterium, or
There are symbiotic bacteria.

・Lactobacillus plantalum 
 :乳酸桿菌で糖質を乳酸に変える。動物の消化器1口
こう等に多く生息する。
・Lactobacillus plantalum
: Converts carbohydrates into lactic acid with Lactobacillus. It often lives in the digestive tract and stomach of animals.

・Lactobacillus sporogenes
 :酸敗に関与する菌で悪臭を発して腐敗させる。
・Lactobacillus sporogenes
: Bacteria involved in rancidity, which gives off a foul odor and causes rot.

・トリプチケースソイブロス培地:下記成分配合を精製
水11に溶解して形成される。
- Trypticase soy broth medium: Formed by dissolving the following ingredient combination in purified water 11.

ポリペプトン(カゼインペプトン)  17gポリペプ
トン(大豆ペプトン)3g 塩化ナトリウム            5gリン酸2
カリウム         2.5gブドウ糖    
           2.5g・ソイビーンカゼイン
ダイジェスト寒天培地(後述)二下記成分を精製水11
に熔解して形成されるもので、医薬、化粧品の細菌検査
用として用いられる。
Polypeptone (casein peptone) 17g Polypeptone (soybean peptone) 3g Sodium chloride 5g Phosphoric acid 2
Potassium 2.5g Glucose
2.5g Soy bean casein digest agar medium (described later) 2. Add the following ingredients to purified water 11.
It is formed by melting into a substance, and is used for bacterial testing of pharmaceuticals and cosmetics.

ポリペプトン(カゼインペプトン)  15gポリペプ
トン(大豆ペプトン)     5g塩化ナトリウム 
           5g寒天          
     15g上記菌株が接種されたトリプチケース
ソイブロス培地を30℃で培養し、3日後および7日後
の増殖状況を判定した。判定は、前記ソイビーンカゼイ
ンダイジェスト寒天培地上に上記培地液を塗抹培養し、
使用菌株の凝集性の程度ミならびに、キトサンによる培
地蛋白の凝集性により判断した。また、キトサン無添加
のトリプチケースソイブロス培地をも同様に培養し、結
果を対照とした。
Polypeptone (casein peptone) 15g Polypeptone (soybean peptone) 5g Sodium chloride
5g agar
A trypticase soy broth medium inoculated with 15 g of the above strain was cultured at 30°C, and the growth status was determined after 3 and 7 days. The determination is made by smearing and culturing the above medium on the soybean casein digest agar medium,
Judgment was made based on the degree of aggregation of the bacterial strain used and the aggregation of culture medium proteins due to chitosan. In addition, trypticase soy broth medium without the addition of chitosan was similarly cultured, and the results were used as a control.

結果を第1表に示す。なお、第1表の判定記号は、下記
の通り。
The results are shown in Table 1. The judgment symbols in Table 1 are as follows.

第1表の結果より、キトサン塩を添加したものは、相対
的に、キトサン塩を添加しなかったものに較べ、これら
菌株の増殖を抑止できることが判った。また、キトサン
塩の添加されたものは臭気も発生せず、高い防臭性のあ
ることも判った。
From the results shown in Table 1, it was found that the products to which chitosan salt was added were able to inhibit the growth of these bacterial strains relatively compared to the products to which chitosan salt was not added. It was also found that the products to which chitosan salt was added did not generate any odor and had high odor resistance.

〔実施例〕〔Example〕

つぎに、この発明の実施例について、比較例と併せて説
明する。
Next, examples of the present invention will be described together with comparative examples.

(実施例1〜6.比較例1) 以下に示す各成分のうち、モノステアリン酸グリセリン
からセタノールまでの4成分を80℃で混合熔解させ、
これを同じく80℃に熱した精製水に添加した後ホモジ
ナイザーで乳化し、室温まで冷却して乳液を得た。この
乳液全量に対するキトサンの純分量が第2表に示した値
となるように、キトサンの乳酸塩水溶液(pH5,0,
5重量%水溶液)を加えて試料とした。なお、使用した
キトサン乳酸塩は、極限粘度からの推定分子量1500
0であった。
(Examples 1 to 6. Comparative Example 1) Among the components shown below, four components from glyceryl monostearate to cetanol were mixed and melted at 80 ° C.
This was added to purified water heated to 80°C, emulsified using a homogenizer, and cooled to room temperature to obtain a milky lotion. A chitosan lactate aqueous solution (pH 5.0,
5% by weight aqueous solution) was added to prepare a sample. The chitosan lactate used has an estimated molecular weight of 1500 from the intrinsic viscosity.
It was 0.

く成分配合〉 得られた試料を80℃に加熱して滅菌したのち、あらか
じめ、トリプチケースソイブロス培地で37℃、2日間
培養しておいた、臭気ならびに腐敗の元となる下記3種
類の菌株を、それぞれ、11当たりの菌数が1000〜
10000になるように接種した。
Ingredient combination> After heating the obtained sample to 80℃ and sterilizing it, we cultured it in advance in trypticase soy broth medium at 37℃ for 2 days. For each strain, the number of bacteria per 11 is 1000 ~
The total number of vaccinations was 10,000.

(使用菌株) Staphylococcus aureusBaci
llus 5ubtilis Escherichia coli なお、上記各画のうち、先の二つは前述したとおりであ
り、Escherichia coliは、En te
robac tariaceae科に属し、ダラム陰性
、無胞子の桿菌で動物に寄生し、腸内細菌群の代表菌で
ある。この菌の存在が汚染度の指標となり、病原菌汚染
の危険性を示す。この種の菌が存在すると皮膚分泌物が
分解されて臭気の発生原因となるため、ダラム陰性の汚
染菌の代表として、ここでテストした。
(Used strain) Staphylococcus aureus Bacillus
llus 5ubtilis Escherichia coli Of the above, the first two are as described above, and Escherichia coli is En te
It belongs to the robac tariaceae family, is a Durham-negative, non-sporulating bacillus that parasitizes animals, and is a representative bacterium of the enterobacteria group. The presence of these bacteria serves as an indicator of the degree of contamination, indicating the risk of pathogenic contamination. The presence of this type of bacteria degrades skin secretions and causes odor, so it was tested here as a representative of Durham-negative contaminant bacteria.

これらの試料を30℃で培養し、7日後および30日後
の増殖状況を判定した。判定は、ソイビーンカゼインダ
イジェスト寒天培地上に上記培地液を塗床培養し、使用
菌株の凝集性の程度、ならびに、キトサンによる培地蛋
白の凝集性により判断した。また、乳液の変質を、その
外観の変化で判定し、両者を総合して効果を判定した。
These samples were cultured at 30°C, and the growth status was determined after 7 and 30 days. Judgment was made by culturing the above-mentioned medium solution on a soy bean casein digest agar medium and based on the degree of flocculation of the strain used and the flocculation of the medium protein due to chitosan. In addition, the deterioration of the emulsion was determined by the change in its appearance, and the effect was determined by combining both.

結果を第2表に示す。なお、第2表の判定記号は、下記
の通り。
The results are shown in Table 2. The judgment symbols in Table 2 are as follows.

第2表の結果より、この発明の化粧料たる実施例1〜6
は、いずれも、比較例1に較べて高い抗菌効果を有し、
皮膚の滅菌作用とそれ自体の防腐作用を併せ持っている
ことが判った。
From the results in Table 2, Examples 1 to 6 of the cosmetics of this invention
Both have higher antibacterial effects than Comparative Example 1,
It was found that it has both a sterilizing effect on the skin and its own antiseptic effect.

(実施例7〜10) 下記成分配合からなるデオドラントローションを調整し
、試料溶液とした。
(Examples 7 to 10) Deodorant lotions having the following ingredient formulations were prepared and used as sample solutions.

く成分配合〉 以上の実施例7〜10で調整した試料溶液を用い、以下
の試験を行った。
Component Blend> The following tests were conducted using the sample solutions prepared in Examples 7 to 10 above.

(試 験) 約20cm四方の大きさの局方ガーゼを四つ折りにした
ものの一方に実施例7〜10の試料溶液を、もう一方に
上記成分配合からキトサン塩のみを除いて作成した対照
溶液を、それぞれ、約ice含むようスプレーしたもの
を用意した。試料溶液がスプレーされたガーゼを10名
の被験者の右腋の下に、対照溶液がスプレーされたガー
ゼを10名の被験者の左膝の下に、それぞれ、紙テープ
で貼り、約12時間後にガーゼに移った体臭の差を本人
が評価した。結果を第3表に示す。
(Test) A piece of pharmacopoeia gauze with a size of approximately 20 cm square was folded into four. On one side, the sample solutions of Examples 7 to 10 were placed, and on the other side, a control solution prepared by excluding only the chitosan salt from the above ingredient combination was placed. , each of which was sprayed to contain approximately ice was prepared. The gauze sprayed with the sample solution was applied under the right armpit of 10 subjects, and the gauze sprayed with the control solution was applied below the left knee of 10 subjects with paper tape, and the gauze was transferred to the gauze after about 12 hours. Participants themselves evaluated the differences in body odor. The results are shown in Table 3.

また、試験後、ガーゼの接触していた腋の下を観察した
ところ、いずれのキトサン濃度においても、刺激による
アレルギー症状等は認められなかった。
Furthermore, after the test, when the armpits that had been in contact with the gauze were observed, no allergic symptoms due to irritation were observed at any chitosan concentration.

第3表の結果より、この発明の化粧料たる実施例7〜l
Oによれば、僅かに効果の差を認めるものをも含めば、
明らかな防臭効果の得られることが判った。
From the results in Table 3, Examples 7 to 1 of the cosmetics of this invention
According to O, including those with slight differences in effectiveness,
It was found that a clear deodorizing effect can be obtained.

〔発明の効果〕〔Effect of the invention〕

この発明の化粧料は、以上のようであり、キトサンが水
溶性酸塩の形で有効成分として配合されてなるものであ
るため、防臭性、抗菌性が高く、かつ、刺激性、毒性、
アレルギー性等を有していないため生体適合性に優れた
安全なものとなっている。
As described above, the cosmetic of the present invention contains chitosan as an active ingredient in the form of a water-soluble acid salt, so it has high deodorizing and antibacterial properties, and is free from irritation, toxicity, and
Since it has no allergic properties, it is safe and has excellent biocompatibility.

Claims (2)

【特許請求の範囲】[Claims] (1)キトサンが水溶性酸塩の形で有効成分として配合
されていることを特徴とする化粧料。
(1) A cosmetic product characterized by containing chitosan as an active ingredient in the form of a water-soluble acid salt.
(2)キトサンの水溶性酸塩の添加量が10重量%以上
である特許請求の範囲第1項記載の化粧料。
(2) The cosmetic according to claim 1, wherein the amount of the water-soluble acid salt of chitosan added is 10% by weight or more.
JP62126540A 1987-05-23 1987-05-23 Cosmetics Expired - Fee Related JP2507425B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62126540A JP2507425B2 (en) 1987-05-23 1987-05-23 Cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62126540A JP2507425B2 (en) 1987-05-23 1987-05-23 Cosmetics

Publications (2)

Publication Number Publication Date
JPS63290808A true JPS63290808A (en) 1988-11-28
JP2507425B2 JP2507425B2 (en) 1996-06-12

Family

ID=14937717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62126540A Expired - Fee Related JP2507425B2 (en) 1987-05-23 1987-05-23 Cosmetics

Country Status (1)

Country Link
JP (1) JP2507425B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016164A1 (en) * 1995-10-28 1997-05-09 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
EP0803513A1 (en) * 1994-03-18 1997-10-29 Kao Corporation Fine porous particle and cosmetic
US5968488A (en) * 1996-10-21 1999-10-19 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations containing cationic biopolymers, aluminum hydrochlorate and esterase inhibitors
EP1106168A1 (en) * 1999-12-07 2001-06-13 Cognis Corporation Use of chitosan for making shaving compositions
JP2002542180A (en) * 1999-04-20 2002-12-10 バイオテク エイエスエイ Deodorant preparation
WO2003068182A1 (en) * 2002-02-15 2003-08-21 Cognis Deutschland Gmbh & Co. Kg Deodorizing preparations containing chitosans and/or chitosan derivatives
US6916465B2 (en) 2000-03-23 2005-07-12 Cognis Deutschland Gmbh & Co. Kg Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives
JP2005336077A (en) * 2004-05-25 2005-12-08 Natural Health Labo:Kk Prophylactic/therapeutic agent for stomatitis
JP2014533667A (en) * 2011-11-22 2014-12-15 クラリアント・ファイナンス・(ビーブイアイ)・リミテッド Use of isosorbide caprylate / caprate in body odor prevention and antiperspirant

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919040A (en) * 1972-04-18 1974-02-20
JPS58164601A (en) * 1982-03-26 1983-09-29 Kohjin Co Ltd Production of water-soluble chitosan salt
JPS59139310A (en) * 1983-01-31 1984-08-10 Shiseido Co Ltd Emulsified composition
JPS59152312A (en) * 1983-02-18 1984-08-31 Lion Corp Oral cavity composition
JPS60203602A (en) * 1983-12-06 1985-10-15 サノフイ Chitosan 6-sulfate and manufacture
JPS61254517A (en) * 1985-05-07 1986-11-12 Shiseido Co Ltd Skin protecting agent
JPS62221615A (en) * 1986-03-19 1987-09-29 Lion Corp Hair cosmetic composition
JPS6314714A (en) * 1986-07-04 1988-01-21 Lion Corp Detergent composition for false tooth

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919040A (en) * 1972-04-18 1974-02-20
JPS58164601A (en) * 1982-03-26 1983-09-29 Kohjin Co Ltd Production of water-soluble chitosan salt
JPS59139310A (en) * 1983-01-31 1984-08-10 Shiseido Co Ltd Emulsified composition
JPS59152312A (en) * 1983-02-18 1984-08-31 Lion Corp Oral cavity composition
JPS60203602A (en) * 1983-12-06 1985-10-15 サノフイ Chitosan 6-sulfate and manufacture
JPS61254517A (en) * 1985-05-07 1986-11-12 Shiseido Co Ltd Skin protecting agent
JPS62221615A (en) * 1986-03-19 1987-09-29 Lion Corp Hair cosmetic composition
JPS6314714A (en) * 1986-07-04 1988-01-21 Lion Corp Detergent composition for false tooth

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1078891C (en) * 1994-03-18 2002-02-06 花王株式会社 Fine porous particle and cosmetic thereof
EP0803513A1 (en) * 1994-03-18 1997-10-29 Kao Corporation Fine porous particle and cosmetic
EP0803513A4 (en) * 1994-03-18 1998-04-08 Kao Corp Fine porous particle and cosmetic
US5770187A (en) * 1994-03-18 1998-06-23 Kao Corporation Porous particulate and cosmetic
WO1997016164A1 (en) * 1995-10-28 1997-05-09 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
US5968488A (en) * 1996-10-21 1999-10-19 Henkel Kommanditgesellschaft Auf Aktien Deodorizing preparations containing cationic biopolymers, aluminum hydrochlorate and esterase inhibitors
JP2002542180A (en) * 1999-04-20 2002-12-10 バイオテク エイエスエイ Deodorant preparation
EP1106168A1 (en) * 1999-12-07 2001-06-13 Cognis Corporation Use of chitosan for making shaving compositions
US6916465B2 (en) 2000-03-23 2005-07-12 Cognis Deutschland Gmbh & Co. Kg Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives
WO2003068182A1 (en) * 2002-02-15 2003-08-21 Cognis Deutschland Gmbh & Co. Kg Deodorizing preparations containing chitosans and/or chitosan derivatives
JP2005336077A (en) * 2004-05-25 2005-12-08 Natural Health Labo:Kk Prophylactic/therapeutic agent for stomatitis
JP2014533667A (en) * 2011-11-22 2014-12-15 クラリアント・ファイナンス・(ビーブイアイ)・リミテッド Use of isosorbide caprylate / caprate in body odor prevention and antiperspirant
JP2018052947A (en) * 2011-11-22 2018-04-05 クラリアント・ファイナンス・(ビーブイアイ)・リミテッド Use of isosorbide caprylates/caprates in deodorants and antiperspirants

Also Published As

Publication number Publication date
JP2507425B2 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
EP0934742B1 (en) Anti-microbial cleansers
JPH07330505A (en) Antimicrobial composition
CA2688736C (en) Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
KR100541271B1 (en) Antimicrobial compositions for topical use
US10792258B2 (en) Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
KR20040033376A (en) Cosmetics composition comprising sophorolipids
CN105658055A (en) Antimicrobial compositions
JPS63290808A (en) Cosmetic
KR20090038648A (en) A composition using the cosmetic containing chamaecyparis obtusa oil for a pimpled skin
CN1322815C (en) Method for preparing the bactericide and the cleansing facial milk]
JP2004307484A (en) Antiseptic bactericide, and cosmetic, pharmaceutical and foodstuff blended with the same
JP4565275B2 (en) Antibacterial composition
EP3723714B1 (en) Propanediol monoacetate mononitrate
JPH04288017A (en) Treating agent for pimple
JPH11199433A (en) Use of honey as agent to reduce adherence of microbe
EP1638516B1 (en) Barrier formulation comprising a silicone based emulsion
WO2019002400A1 (en) Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an aromatic alcohol, and cosmetic composition containing same
KR100513301B1 (en) A composition for washing foot
EP3485869B1 (en) Use of phytantriol as an antimicrobial agent in the preservation of a composition
JP2003113097A (en) External preparation including aureobasidium culture solution
JPH11302147A (en) Cosmetic
CN110831570A (en) New use
JP2018052891A (en) Liniment for controlling resident skin bacteria
JPS62273905A (en) Cosmetic
CN114096229B (en) Use of dianhydrohexitols for eliminating the effects of acne, dandruff and malodour on the instrumentation of the appearance

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees